Comparison of the effects of weekly and biweekly intravenous CERA administration on erythropoiesis: A randomized controlled trial

Although continuous erythropoietin receptor activators (CERAs) are widely used erythropoiesis‐stimulating agents for correcting renal anemia in patients undergoing hemodialysis (HD), few reports have examined weekly CERA administration. In this randomized controlled trial, we compared the efficacy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawai, Yuki, Toya, Yoshiyuki, Wakui, Hiromichi, Fujikawa, Tetsuya, Ueda, Eiko, Azushima, Kengo, Mitsuhashi, Hiroshi, Kawano, Tomoyuki, Kuji, Tadashi, Yamaguchi, Satoshi, Ohnishi, Toshimasa, Tamura, Kouichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Erythropoietin
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678717/
https://www.ncbi.nlm.nih.gov/pubmed/33481341
http://dx.doi.org/10.1111/jch.14171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678717/
https://www.ncbi.nlm.nih.gov/pubmed/33481341
http://dx.doi.org/10.1111/jch.14171

Ejemplares similares